Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-1,41%
1 076,13
-15,38
-1,41%
—1 091,511 090,401 090,401 073,69——
SIXC
Communications
SIXC
Communications
SIXC
-0,55%
606,74
-3,37
-0,55%
—610,11610,11610,29606,17——
SIXE
Energy
SIXE
Energy
SIXE
+0,88%
1 248,82
+10,84
+0,88%
—1 237,981 237,831 252,411 225,03——
SIXI
Industrials
SIXI
Industrials
SIXI
-1,17%
1 724,36
-20,35
-1,17%
—1 744,711 740,951 747,291 721,57——
SIXM
Financials
SIXM
Financials
SIXM
-0,72%
635,59
-4,59
-0,72%
—640,18639,92643,19634,73——
SIXR
Staples
SIXR
Staples
SIXR
-0,76%
843,15
-6,43
-0,76%
—849,58845,27851,68839,47——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,55%
216,29
-1,19
-0,55%
—217,48217,48218,16215,51——
SIXT
Technology
SIXT
Technology
SIXT
+0,08%
3 263,41
+2,72
+0,08%
—3 260,693 273,363 287,813 240,78——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,34%
939,24
-3,21
-0,34%
—942,45939,39948,80933,98——
SIXV
Health care
SIXV
Health care
SIXV
-0,29%
1 462,56
-4,24
-0,29%
—1 466,801 464,701 467,191 458,36——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0,71%
2 380,40
-17,10
-0,71%
—2 397,502 395,032 412,012 370,64——
M1RN34:BVMF
Moderna Inc Bdr
R$11,75
+5,67%
(+0,63) 1D
4 Mei, 17:10:00 GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for M1RN34...
Open
R$11,14
High
R$11,86
Low
R$11,14
Mkt. cap
18,76 mjd
Avg. vol.
22,08 k
Volume
46,91 k
52-wk high
R$15,53
52-wk low
R$6,02
Shares outstanding
396,59 m
No. of employees
5 k
News stories
From sources across the web
Profile
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern". The company's commercial products are the Moderna COVID-19 vaccine, marketed as Spikevax and a respiratory syncytial virus vaccine, marketed as Mresvia. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines. Wikipedia
About Moderna Inc Bdr
CEOStéphane Bancel
Employees4,7 k
FoundedSep. 2010
Headquarters-
Sector-
Websitemodernatx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mrt. 2025
Jun. 2025
Sep. 2025
Des. 2025
Revenue
108,00 m
142,00 m
1,02 mjd
678,00 m
Cost of goods sold
946,00 m
819,00 m
1,01 mjd
1,23 mjd
Cost of revenue
946,00 m
819,00 m
1,01 mjd
1,23 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
212,00 m
230,00 m
268,00 m
308,00 m
Operating expense
212,00 m
230,00 m
268,00 m
308,00 m
Total operating expenses
1,16 mjd
1,05 mjd
1,28 mjd
1,54 mjd
Operating income
-1,05 mjd
-907,00 m
-260,00 m
-857,00 m
Other non operating income
4,00 m
9,00 m
-4,00 m
-2,00 m
EBT including unusual items
-964,00 m
-818,00 m
-187,00 m
-799,00 m
EBT excluding unusual items
-957,00 m
-818,00 m
-191,00 m
-797,00 m
Income tax expense
7,00 m
7,00 m
13,00 m
27,00 m
Effective tax rate
-0,73%
-0,86%
-6,95%
-3,38%
Other operating expenses
-
-
-
-
Net income
-971,00 m
-825,00 m
-200,00 m
-826,00 m
Net profit margin
-899,07%
-580,99%
-19,68%
-121,83%
Earnings per share
-2,52
-2,13
-0,51
-2,11
Interest and investment income
90,00 m
81,00 m
73,00 m
70,00 m
Interest expense
-1,00 m
-1,00 m
-
-8,00 m
Net interest expenses
89,00 m
80,00 m
73,00 m
62,00 m
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,01 mjd
-850,00 m
-208,00 m
-790,00 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer